Literature DB >> 33275271

Psychopathological profile in COVID-19 patients including healthcare workers: the implications.

D P R Chieffo1, V Delle Donne, V Massaroni, L Mastrilli, D Belella, L Monti, M C Silveri, R Cauda.   

Abstract

OBJECTIVE: The effects of COVID-19 seem to extend beyond the physical pain and is showing psychiatric implications as well. Moreover, psychopathological implications seem to last also after patients' discharge. Our goal is to investigate the psychological impact and psychopathological outcome of patients affected by COVID-19. PATIENTS AND METHODS: We have engaged 34 patients with COVID-19 conditions [eight of them were healthcare workers patients (HCW)] hospitalized at "Policlinico Gemelli Foundation" of Rome, Italy. All patients were evaluated through the Impact of Event Scale-Revised (IES-R) and the Symptom Checklist 90-R (SCL-90-R) first, during their hospitalization (baseline), and then, after 4 months from hospital discharge (follow-up), through phone interviews.
RESULTS: At baseline, 82% of patients revealed from mild to severe psychological impact of COVID-19, according to the IES-R. At follow-up, the mean IES-R total score was significantly decreased (p<0.001) even if almost half (46.6%) of our cohort still showed it. HCW patients showed a significantly higher score than other patients at IES-R scale, both at baseline (p=0.005) and at follow-up (p<0.001). Moreover, at 4 months from discharge, they showed a significantly higher percentage of moderate and severe distress (p=0.015). In addition to this, at follow-up, our cohort of patients showed an increase of anxiety symptoms, even if not significant compared to baseline (46.7% vs. 35.3% respectively; p=1.000), and HCW patients suffered more sleep disorders (p=0.019) and anxiety symptoms (p=0.019) compared to other patients.
CONCLUSIONS: We indicate the importance of assessing psychopathology of COVID-19 survivors, monitoring their changes over time, and providing psychological support to improve their psychological well-being.

Entities:  

Year:  2020        PMID: 33275271     DOI: 10.26355/eurrev_202011_23858

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  5 in total

1.  Experiences of COVID-19-Recovered Healthcare Workers in a Tertiary Hospital in the Philippines: A Mixed-Method Inquiry.

Authors:  Mark B Carascal; Pedro E Capistrano; Marlouie D L Figueras; Osmuniard Lanz Angelo C Cataylo; Spencer Mathew S Zuñiga; Marc Eric S Reyes; Kathleen Kaye S Medriano; Anthony T Gamo; Paz D Mendoza; Shirley Luz B Macalipay
Journal:  Inquiry       Date:  2022 Jan-Dec       Impact factor: 2.099

2.  Short-Term Consequences of SARS-CoV-2-Related Pneumonia: A Follow Up Study.

Authors:  Gianluca E M Boari; Silvia Bonetti; Federico Braglia-Orlandini; Giulia Chiarini; Cristina Faustini; Gianluca Bianco; Marzia Santagiuliana; Vittoria Guarinoni; Michele Saottini; Sara Viola; Giulia Ferrari-Toninelli; Giancarlo Pasini; Bianca Bonzi; Paolo Desenzani; Claudia Tusi; Paolo Malerba; Eros Zanotti; Daniele Turini; Damiano Rizzoni
Journal:  High Blood Press Cardiovasc Prev       Date:  2021-04-28

Review 3.  Post-viral mental health sequelae in infected persons associated with COVID-19 and previous epidemics and pandemics: Systematic review and meta-analysis of prevalence estimates.

Authors:  Simeon Joel Zürcher; Céline Banzer; Christine Adamus; Anja I Lehmann; Dirk Richter; Philipp Kerksieck
Journal:  J Infect Public Health       Date:  2022-04-20       Impact factor: 7.537

4.  What might COVID-19 patients experience after recovery? A comprehensive review.

Authors:  Rehab Elhiny; Ali Azeez Al-Jumaili; Mohammed Jamal Yawuz
Journal:  Int J Pharm Pract       Date:  2022-07-26

5.  Cross-sectional investigation and correlation analysis of psychology of college students returning to campus after COVID-19 lockdown lift.

Authors:  Zhifeng Wang; Bing Jiang; Xingtong Wang; Yi Niu; Haihong Xue
Journal:  Front Psychiatry       Date:  2022-07-22       Impact factor: 5.435

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.